LymphedemaV1, Main, Exploration, bibRecord, 008635

Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up

Identifieur interne : 008635 ( Main/Exploration ); précédent : 008634; suivant : 008636

Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up

Auteurs : Sandi Hayes [Australie] ; Bruce Cornish [Australie] ; Beth Newman [Australie]

Source :

Breast cancer research and treatment [ 0167-6806 ] ; 2005.

RBID : Pascal:05-0183103

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (anatomopathologie), Adénocarcinome (mortalité), Adénocarcinome mucineux (), Adénocarcinome mucineux (anatomopathologie), Adénocarcinome mucineux (mortalité), Carcinome canalaire du sein (), Carcinome canalaire du sein (anatomopathologie), Carcinome canalaire du sein (mortalité), Carcinome médullaire (), Carcinome médullaire (anatomopathologie), Carcinome médullaire (mortalité), Facteurs de risque, Femelle, Humains, Impédance électrique, Lymphadénectomie, Lymphoedème (diagnostic), Mastectomie partielle, Queensland, Récepteurs des oestrogènes (métabolisme), Récepteurs à la progestérone (métabolisme), Sujet âgé, Survivants, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (mortalité), Études de suivi.
MESH :
- anatomopathologie : Adénocarcinome, Adénocarcinome mucineux, Carcinome canalaire du sein, Carcinome médullaire, Tumeurs du sein.
- diagnostic : Lymphoedème.
- mortalité : Adénocarcinome, Adénocarcinome mucineux, Carcinome canalaire du sein, Carcinome médullaire, Tumeurs du sein.
- métabolisme : Récepteurs des oestrogènes, Récepteurs à la progestérone.
Pascal (Inist)
- Adulte d'âge moyen, Adénocarcinome, Adénocarcinome mucineux, Carcinome canalaire du sein, Carcinome médullaire, Facteurs de risque, Femelle, Humains, Impédance électrique, Lymphadénectomie, Lymphoedème, Etude comparative, Mastectomie partielle, Méthode, Glande mammaire pathologie, Queensland, Sujet âgé, Survivants, Tumeur maligne, Homme, Survivant, Prévalence, Epidémiologie, Facteur risque, Cancer sein, Tumeurs du sein, Études de suivi.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adenocarcinoma (mortality), Adenocarcinoma (pathology), Adenocarcinoma (therapy), Adenocarcinoma, Mucinous (mortality), Adenocarcinoma, Mucinous (pathology), Adenocarcinoma, Mucinous (therapy), Aged, Breast Neoplasms (mortality), Breast Neoplasms (pathology), Breast Neoplasms (therapy), Breast cancer, Carcinoma, Ductal, Breast (mortality), Carcinoma, Ductal, Breast (pathology), Carcinoma, Ductal, Breast (therapy), Carcinoma, Medullary (mortality), Carcinoma, Medullary (pathology), Carcinoma, Medullary (therapy), Comparative study, Electric Impedance, Epidemiology, Female, Follow-Up Studies, Human, Humans, Lymph Node Excision, Lymphedema, Lymphedema (diagnosis), Malignant tumor, Mammary gland diseases, Mastectomy, Segmental, Method, Middle Aged, Prevalence, Queensland, Receptors, Estrogen (metabolism), Receptors, Progesterone (metabolism), Risk Factors, Risk factor, Survivor, Survivors.
MESH :
- chemical , metabolism : Receptors, Estrogen, Receptors, Progesterone.
- geographic : Queensland.
- diagnosis : Lymphedema.
- mortality : Adenocarcinoma, Adenocarcinoma, Mucinous, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Medullary.
- pathology : Adenocarcinoma, Adenocarcinoma, Mucinous, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Medullary.
- therapy : Adenocarcinoma, Adenocarcinoma, Mucinous, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Medullary.
- Aged, Electric Impedance, Female, Follow-Up Studies, Humans, Lymph Node Excision, Mastectomy, Segmental, Middle Aged, Risk Factors, Survivors.

Abstract

One of the more problematic and dreaded complications of breast cancer is lymphoedema. Our objective was to determine the prevalence of lymphoedema 6-months following breast cancer treatment and to examine potential risk factors among a population-based sample of women residing in South-East Queensland (n = 176). Women were defined as having lymphoedema if the difference between the sum of arm circumferences (SOAC) of the treated and untreated sides was >5 cm (prevalence = 11.9%) or > 10% (prevalence = 0.6%), their multifrequency bioelectrical impedance (MFBIA) score was ≥3 standard deviations above the reference impedance score (prevalence = 11.4%), or they reported 'yes' when asked if arm swelling had been present in the previous 6 months (prevalence = 27.8%). Of those with lymphoedema defined by MFBIA, only 35% were detected using the SOAC method (difference > 5 cm), while 65% were identified via the self-report method (i.e., respective sensitivities). Specificities for SOAC (difference > 5 cm) and self-report were 88.5% and 76.9%, respectively. When examining associations between presence of lymphoedema and a range of characteristics, findings also varied depending on the method used to assess lymphoedema. Nevertheless, one of the more novel and significant findings was that being treated on the non-dominant, compared to dominant, side was associated with an 80% increased risk of having lymphoedema (MFBIA). Our work raises questions about the use of circumferences as the choice of measurement for lymphoedema in both research and clinical settings, and assesses MFBIA as a potential alternative.

Affiliations:

Australie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up</title>
<author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Public Health, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Human Movement Studies, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cornish, Bruce" sort="Cornish, Bruce" uniqKey="Cornish B" first="Bruce" last="Cornish">Bruce Cornish</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>School of Physical and Chemical Sciences, Queensland University of Technology</s1>
<s2>Brisbane, Queensland</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Public Health, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0183103</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0183103 INIST</idno>
<idno type="RBID">Pascal:05-0183103</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000584</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000376</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000587</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000587</idno>
<idno type="wicri:doubleKey">0167-6806:2005:Hayes S:comparison:of:methods</idno>
<idno type="wicri:Area/Main/Merge">008863</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15754119</idno>
<idno type="wicri:Area/PubMed/Corpus">003D46</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003D46</idno>
<idno type="wicri:Area/PubMed/Curation">003D46</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003D46</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D46</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003D46</idno>
<idno type="wicri:Area/Ncbi/Merge">001D50</idno>
<idno type="wicri:Area/Ncbi/Curation">001D50</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D50</idno>
<idno type="wicri:doubleKey">0167-6806:2005:Hayes S:comparison:of:methods</idno>
<idno type="wicri:Area/Main/Merge">008237</idno>
<idno type="wicri:Area/Main/Curation">008635</idno>
<idno type="wicri:Area/Main/Exploration">008635</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up</title>
<author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Public Health, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Human Movement Studies, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cornish, Bruce" sort="Cornish, Bruce" uniqKey="Cornish B" first="Bruce" last="Cornish">Bruce Cornish</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>School of Physical and Chemical Sciences, Queensland University of Technology</s1>
<s2>Brisbane, Queensland</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queensland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Public Health, Centre for Health Research</s1>
<s2>Brisbane, Queenstand</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Brisbane, Queenstand</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (mortality)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adenocarcinoma (therapy)</term>
<term>Adenocarcinoma, Mucinous (mortality)</term>
<term>Adenocarcinoma, Mucinous (pathology)</term>
<term>Adenocarcinoma, Mucinous (therapy)</term>
<term>Aged</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Breast cancer</term>
<term>Carcinoma, Ductal, Breast (mortality)</term>
<term>Carcinoma, Ductal, Breast (pathology)</term>
<term>Carcinoma, Ductal, Breast (therapy)</term>
<term>Carcinoma, Medullary (mortality)</term>
<term>Carcinoma, Medullary (pathology)</term>
<term>Carcinoma, Medullary (therapy)</term>
<term>Comparative study</term>
<term>Electric Impedance</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymphedema</term>
<term>Lymphedema (diagnosis)</term>
<term>Malignant tumor</term>
<term>Mammary gland diseases</term>
<term>Mastectomy, Segmental</term>
<term>Method</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Queensland</term>
<term>Receptors, Estrogen (metabolism)</term>
<term>Receptors, Progesterone (metabolism)</term>
<term>Risk Factors</term>
<term>Risk factor</term>
<term>Survivor</term>
<term>Survivors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome ()</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Adénocarcinome (mortalité)</term>
<term>Adénocarcinome mucineux ()</term>
<term>Adénocarcinome mucineux (anatomopathologie)</term>
<term>Adénocarcinome mucineux (mortalité)</term>
<term>Carcinome canalaire du sein ()</term>
<term>Carcinome canalaire du sein (anatomopathologie)</term>
<term>Carcinome canalaire du sein (mortalité)</term>
<term>Carcinome médullaire ()</term>
<term>Carcinome médullaire (anatomopathologie)</term>
<term>Carcinome médullaire (mortalité)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Impédance électrique</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème (diagnostic)</term>
<term>Mastectomie partielle</term>
<term>Queensland</term>
<term>Récepteurs des oestrogènes (métabolisme)</term>
<term>Récepteurs à la progestérone (métabolisme)</term>
<term>Sujet âgé</term>
<term>Survivants</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptors, Estrogen</term>
<term>Receptors, Progesterone</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Queensland</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Adénocarcinome mucineux</term>
<term>Carcinome canalaire du sein</term>
<term>Carcinome médullaire</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Adenocarcinoma</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
<term>Carcinoma, Medullary</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Adénocarcinome</term>
<term>Adénocarcinome mucineux</term>
<term>Carcinome canalaire du sein</term>
<term>Carcinome médullaire</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Récepteurs des oestrogènes</term>
<term>Récepteurs à la progestérone</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
<term>Carcinoma, Medullary</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
<term>Carcinoma, Medullary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Electric Impedance</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Risk Factors</term>
<term>Survivors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome</term>
<term>Adénocarcinome mucineux</term>
<term>Carcinome canalaire du sein</term>
<term>Carcinome médullaire</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Impédance électrique</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème</term>
<term>Etude comparative</term>
<term>Mastectomie partielle</term>
<term>Méthode</term>
<term>Glande mammaire pathologie</term>
<term>Queensland</term>
<term>Sujet âgé</term>
<term>Survivants</term>
<term>Tumeur maligne</term>
<term>Homme</term>
<term>Survivant</term>
<term>Prévalence</term>
<term>Epidémiologie</term>
<term>Facteur risque</term>
<term>Cancer sein</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">One of the more problematic and dreaded complications of breast cancer is lymphoedema. Our objective was to determine the prevalence of lymphoedema 6-months following breast cancer treatment and to examine potential risk factors among a population-based sample of women residing in South-East Queensland (n = 176). Women were defined as having lymphoedema if the difference between the sum of arm circumferences (SOAC) of the treated and untreated sides was >5 cm (prevalence = 11.9%) or > 10% (prevalence = 0.6%), their multifrequency bioelectrical impedance (MFBIA) score was ≥3 standard deviations above the reference impedance score (prevalence = 11.4%), or they reported 'yes' when asked if arm swelling had been present in the previous 6 months (prevalence = 27.8%). Of those with lymphoedema defined by MFBIA, only 35% were detected using the SOAC method (difference > 5 cm), while 65% were identified via the self-report method (i.e., respective sensitivities). Specificities for SOAC (difference > 5 cm) and self-report were 88.5% and 76.9%, respectively. When examining associations between presence of lymphoedema and a range of characteristics, findings also varied depending on the method used to assess lymphoedema. Nevertheless, one of the more novel and significant findings was that being treated on the non-dominant, compared to dominant, side was associated with an 80% increased risk of having lymphoedema (MFBIA). Our work raises questions about the use of circumferences as the choice of measurement for lymphoedema in both research and clinical settings, and assesses MFBIA as a potential alternative.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
</noRegion>
<name sortKey="Cornish, Bruce" sort="Cornish, Bruce" uniqKey="Cornish B" first="Bruce" last="Cornish">Bruce Cornish</name>
<name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
<name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008635 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008635 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0183103
   |texte=   Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up

Comparison of methods to diagnose lymphoedema among breast cancer survivors : 6-month follow-up

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.